When a policyholder is denied a legitimate claim, the failure does not belong to them alone. It belongs to the insurer that drafted an unreadable contract, the regulator that approved it without scrutiny, the legislature that wrote rules favorable to industry, and the bureaucracy that made appeal so exhausting that most people simply give up. This is not a market malfunction. It is a market Design.
Consider the transaction at the heart of every insurance policy. A person hands over money, regularly, reliably, often for decades, in exchange for a promise. The promise is simple: when the worst happens, you will not face it alone. This is not a luxury product.It is, in many jurisdictions, a legal requirement. It is sold as security, marketed as peace of mind, and positioned as one of the foundational pillars of financial responsibility. And when that promise is broken, not because of fraud, not because of deception, but because an insurer found a clause, a condition, or a procedural failure to justify non-payment, the entire premise of insurance collapses.
What follows is not an argument against the insurance industry as a concept. It is an argument against the industry as it is currently practiced, regulated, and protected by law. And it implicates not just insurers, but the regulators who oversee them, the legislators who enable them, the courts that defer to them, and the bureaucratic architecture that has been built, quietly and deliberately, to make accountability as difficult as possible for the people who need it most.
The scale of the problem is not in dispute. Claim denial rates in health insurance alone run into tens of millions annually. Internal appeals are upheld by insurers at rates that would embarrass any independent arbitration body. Regulatory complaints are processed at timescales that would be considered scandalous in any other sector touching public welfare. And all of this unfolds against a backdrop of rising premiums, expanding exclusions, and an industry that reported record profits in the same years it tightened claim approvals. These facts are not unrelated. They are structurally connected.
The industry did not stumble into a system that favors denial. It built one, refined it over decades, and then asked regulators to bless it.
THE CONTRACT THAT WAS NEVER MEANT TO BE READ
Insurance contracts are, by design, incomprehensible to the people who sign them. This is not accidental. Policy documents routinely run to sixty, eighty, sometimes more than ahundred pages. They are written in language that combines legal precision with deliberate opacity. Definitions are circular. Exclusions are nested within exclusions.Coverage that appears clearly granted in one section is quietly withdrawn in another.
And the entire structure is presented as a take-it-or-leave-it offering, because for most people, in most insurance categories, it is.
Regulators are supposed to review these documents before they enter the market. In many jurisdictions, they do. The question that has never been adequately answered is what exactly they are reviewing for. If the standard is whether the contract is technically lawful, most policies pass easily. If the standard is whether an ordinary person can understand what they are buying, most policies would fail on the first page. Regulatory approval of an insurance contract is not a consumer guarantee. It is a legal formality, and the industry has known this for a very long time.
The doctrine of reasonable expectations, which holds that a policyholder is entitled to the coverage a reasonable person would expect from the policy they purchased, exists precisely because courts recognized that literal enforcement of insurance contracts often produced outcomes that bore no relationship to what was sold. But this doctrine is inconsistently applied, varies wildly by jurisdiction, and requires policyholders to litigate to access it. A right that must be won in court after years of proceedings is not a consumer protection. It is a lottery.
What no regulator has yet done, in any comprehensive and enforceable way, is require insurance contracts to be written in plain language, tested for comprehension against a representative sample of the population that will be asked to buy them, and denied market approval if they fail. This would not be technically difficult. It would, however, be politically inconvenient, because it would require the industry to abandon ambiguity, and ambiguity is where the money is.
A contract drafted to be misunderstood is not a contract. It is a trap with a premium attached.
UNDERWRITING AS A ONE-WAY DOOR
The insurance relationship begins with underwriting. The insurer examines the risk, asks questions, reviews disclosures, and makes a professional judgment about whether and on what terms to offer coverage. This process is supposed to be thorough. It is supposed to surface the issues that might later become grounds for dispute. And when it does not, the failure of that process should sit with the party that conducted it, not the party that was subjected to it.
In practice, underwriting has become something quite different. Insurers have discovered that it is more profitable to accept premiums with minimal scrutiny and investigate only at claim time. The term for this in the industry is post-claim underwriting, and while it is prohibited in certain forms in certain jurisdictions, its functional equivalent persists across the market. An insurer that accepts ten years of health insurance premiums and then discovers, when a major claim is filed, that the policyholder failed to disclose a minor and irrelevant prior condition, is not engaging in legitimate claims management. It is conducting underwriting in reverse, using the claim as the trigger for the investigation that should have been done before the policy was issued.
The legal framework that permits this is built on a fiction: that policyholders bear equal responsibility for the completeness and accuracy of the insurance application. This might be defensible if insurers asked precise, clear, and complete questions at the application stage. Most do not. Questions about medical history are frequently broad, poorly defined, and subject to interpretations the applicant has no way of anticipating.
When an insurer later argues that a condition was not disclosed, it often means that a question was asked ambiguously, answered in good faith, and then reinterpreted adversarially when money was at stake.
Regulators have the authority to require rigorous upfront underwriting as a condition of market participation. They have largely chosen not to exercise it. The result is an industry that collects premiums on the basis of risk it has not properly assessed, and then refuses to pay claims on the basis of that unassessed risk. This is not a gap in the regulatory framework. It is the regulatory framework working exactly as the industry prefers.
THE BUREAUCRACY OF DENIAL
Denying a claim is easy. One letter, one code, one clause. Appealing a denial is a different matter entirely. It requires navigating a process that is, in most jurisdictions, designed by the insurer, administered by the insurer, and decided by the insurer. The internal appeals mechanism that most insurance contracts and regulatory frameworks require as a precondition to external review is, in practice, a formality. Internal appeal overturn rates in health insurance in the United States hover in the low single digits. The process exists not to provide justice but to create a procedural record that makes subsequent legal challenge more difficult.
The external review mechanisms that follow are marginally better, but they too are subject to constraints that favor the insurer. Timelines for resolution stretch to months or years. Legal costs for individual claimants are prohibitive relative to the value of most contested claims. And the very complexity of insurance contracts means that external reviewers, whether arbitrators, ombudsmen, or courts, must frequently defer to the insurer’s interpretation of ambiguous language because ambiguity, in most legal frameworks, is resolved in favor of the drafter.
This is the bureaucratic architecture of denial. It is not a series of neutral administrative steps. It is an attrition strategy. Insurers understand, because their own data tells them, that a significant proportion of denied claimants will not appeal. Of those who do appeal internally, most will not proceed to external review. Of those who seek external review, most will not litigate. At every stage, the complexity, cost, and time required to pursue a claim functions as a filter that removes from the process the people who most need it, because they are the ones who can least afford to wait.
Regulatory bodies are aware of this. Claims management conduct has been the subject of regulatory review in jurisdiction after jurisdiction, and the findings are remarkably consistent. Delays are systemic. Communication is inadequate. Appeal processes are poorly explained. And penalties for non-compliance are calibrated not to deter but to be absorbed as a cost of doing business. A fine that represents a fraction of a percent of annual premium revenue is not a deterrent. It is a licensing fee for misconduct.
The appeals process was not built to correct wrong decisions. It was built to exhaust the people trying to challenge them.
WHEN HEALTH IS THE CASUALTY
In most commercial disputes, the stakes are financial. In health insurance, they are not. A delayed authorization for a surgical procedure is not an inconvenience. It is a medical decision made by a person with no clinical qualification, on behalf of a company with a financial interest in the outcome, overriding the judgment of a physician who has examined the patient. The normalization of this practice is one of the most remarkable failures of health policy in the modern era.
Prior authorization requirements, which compel physicians to obtain insurer approval before providing care that they have clinically determined is necessary, have expanded dramatically over the past two decades. There is no credible evidence that this expansion has improved patient outcomes. There is substantial evidence that it has delayed necessary treatment, increased physician burnout, and in documented cases, contributed directly to patient deterioration and death.Â
The American Medical Association surveys its members annually on this subject. The results are unambiguous. And yet the practice continues, because the savings it generates for insurers are real and the harms it causes are distributed, diffuse, and difficult to attribute cleanly to a single decision.
Emergency claims present an even sharper version of this problem. When a person arrives at an emergency room, they do not negotiate coverage in advance. They receive care. The dispute about what that care costs, and how much the insurer will pay, comes afterward. In the interim, the patient receives a bill, the provider absorbs an uncertainty, and the insurer holds the money.Â
Every day of administrative delay in that situation is a day the insurer retains funds it may legally owe. The interest on that retained capital, across millions of claims, is not trivial. The incentive to delay is built into the financial structure of the relationship.
The policy response to this has been inadequate in almost every respect. Federal and state timelines for claim processing exist on paper. Enforcement is sporadic and penalties are minimal. The fast-track mechanisms that regulators have mandated are often implemented in name only, with insurers meeting the letter of the requirement while systematically violating its spirit. And the patients waiting for authorization, the families appealing denials, the physicians spending hours on hold with insurer representatives, are paying the cost of a regulatory failure that no one in the system has a sufficient incentive to fix.
A health insurer that delays payment on a critical care claim is not processing paperwork. It is making a clinical decision without a license, and a financial one with a conflict of interest.
THE REGULATOR’S COMPLICITY
Regulatory capture is a concept economists and policy scholars discuss with some frequency. It describes the process by which regulatory agencies, over time, come to reflect the interests of the industries they are supposed to oversee rather than the public they are supposed to protect. In the insurance sector, regulatory capture is not a theoretical risk. It is the operational reality in most markets where insurance regulation exists.
Insurance regulators are, in most countries, funded in whole or in part by the industries they regulate. Their senior staff routinely move between regulatory roles and industry positions. The technical expertise required to understand modern insurance products is concentrated in the industry itself, which means regulators are perpetually dependent on the entities they are meant to police for the knowledge necessary to police them.
Rule-making processes are structured in ways that allow industry extensive opportunity to shape regulation before it is finalized, while providing limited equivalent access to consumer groups or public interest advocates.
The consequences are visible in the rules that result. Disclosure requirements that require disclosure without requiring comprehension. Solvency requirements that protect the system without protecting the policyholder within it. Complaint-handling standards that measure process rather than outcome. And premium approval regimes that have, in many jurisdictions, served primarily to prevent competition on price while doing nothing to address competition on coverage or claims service.
When a regulator approves a policy form that contains exclusions no ordinary person would understand, it is not an oversight. It is a choice. When a regulator sets complaint resolution timelines of ninety days for disputes involving acute health conditions, it is not an administrative default.Â
It is a policy position. And when that same regulator imposes a fine on a systemically non-compliant insurer that amounts to less than one day of that insurer’s profit, the message to the industry is not that conduct must change.Â
The message is that the regulator has noticed, and that noticing is as far as it goes.
The regulator who signs off on a contract that no one can understand, and then wonders why consumers feel betrayed, is not asking the right questions about who is actually being protected.
THE LEGISLATURE’S LONG ABDICATION
Behind every inadequate regulator stands an inadequate legislative mandate. Insurance law in most jurisdictions is old, complex, heavily lobbied, and systematically difficult to reform. The insurance industry is among the largest contributors to political campaigns in virtually every democracy where such contributions are tracked. It maintains lobbying operations of considerable sophistication. And it has been extraordinarily effective, over decades, at ensuring that the legislative environment remains conducive to its interests.
The specific mechanisms vary by country, but the pattern is consistent. Proposals for mandatory plain-language policies are met with industry arguments about the complexity of risk, the cost of redrafting, and the unintended consequences of simplification. Proposals for stronger claim denial standards are met with warnings about moral hazard, fraud, and the systemic risks of expanded coverage obligations.
Proposals for meaningful penalty structures are met with projections of premium increases and coverage contractions that may or may not be accurate, but that are presented with the authority of industry actuaries and the backing of industry lobbyists.
The result is a legislative framework that is perpetually one cycle behind the problem it is supposed to address. By the time a specific abuse is legislatively prohibited, the industry has typically developed a functional equivalent.
And the legislators who might otherwise push harder on these issues are the same legislators who receive industry support and who, when they leave office, may find themselves with opportunities in the sector they once regulated. The revolving door between government and industry is not unique to insurance. But in a sector where government approval is the prerequisite for market participation, it has consequences that are felt by every policyholder who has ever received a denial letter.
What is required is not incremental adjustment to existing frameworks. What is required is a fundamental reorientation of where legislative priorities in insurance regulation lie. The purpose of insurance law is not to enable a viable insurance market. A viable insurance market is the means. The purpose is to ensure that when people buy insurance, the promise they are buying is real. Every legislative choice that subordinates that purpose to industry convenience is a choice against the public interest, and it should be named as such.
WHAT ACCOUNTABILITY ACTUALLY LOOKS LIKE
Accountability in the insurance sector is not a vague aspiration. It has specific, concrete, and technically feasible forms. The first is mandatory plain-language contracts, tested against readability standards by independent bodies before regulatory approval, with clear summaries of what is and is not covered displayed prominently rather than buried in appendices. The second is the prohibition of post-claim underwriting in all its functional forms, with a legal presumption that where proper underwriting was not conducted before a policy was issued, subsequent claim denials on underwriting grounds are void.
The third is an independent claims review mechanism with genuine authority. Not an ombudsman with recommendations. Not an arbitration panel with procedural constraints that favor the insurer. A body with the power to overturn denials, impose costs, and publish findings, funded by industry levies but governed independently, with consumer representatives holding genuine decision-making power. The fourth is a mandatory fast- track process for all health-related claims involving acute conditions, with strict and enforceable resolution timelines, automatic penalties for breach, and interim coverage obligations that prevent treatment delays during the review period.
The fifth, and most politically fraught, is penalty reform. Fines for insurance misconduct must be calibrated to deter rather than absorb. A penalty structure that caps fines at amounts the industry regards as negligible is not a regulatory mechanism. It is a permission slip. Penalties must be proportionate to the scale of the violation and the financial capacity of the violator, must escalate with repetition, and must be accompanied by individual accountability for the executives responsible for systemic Non-compliance.
None of these proposals is without complexity. None of them can be implemented without cost. But the costs of implementation are borne primarily by an industry that has, for decades, externalized its costs onto the policyholders it was supposed to serve.
The argument that reform will increase premiums is the same argument that has been made against every consumer protection measure in the history of insurance regulation. It has often been wrong. And even when it has been right, the relevant question is not whether protection costs something. The relevant question is who should bear that cost.
An industry that threatens premium increases every time it is asked to honor its obligations is not making an economic argument. It is making a political one.
THE QUESTION THAT MUST BE ANSWERED
There is a question that sits beneath every argument in this piece, and it deserves to be stated plainly. If insurance companies are collecting premiums in exchange for a promise, and if that promise is routinely broken without meaningful consequence, what exactly are people buying? The answer, for a growing number of policyholders, is the appearance of security rather than the substance of it.
They are buying a document that makes them legally compliant, that satisfies a mortgage requirement or an employment condition or a statutory obligation, but that provides genuine protection only to the policyholders lucky enough to never need to test it.
This is not a fringe critique. It is expressed in survey after survey of consumer experience with insurance. It is reflected in the explosion of complaint volumes to regulatory bodies across multiple markets. It is visible in the litigation statistics, the legislative histories, and the academic literature on insurance market conduct. And it is confirmed, quietly and without fanfare, in the internal documents of insurance companies that have been disclosed in litigation and that reveal a claims management culture oriented around minimization rather than resolution.
The people who pay the price for this are not abstractions. They are the family that remortgaged a house while appealing a health insurance denial. The small business owner whose commercial property claim was rejected on a technicality after twenty years of premiums. The elderly patient told that a procedure deemed medically necessary by three separate physicians falls outside the definition of medical necessity in schedule six of their policy.Â
The common thread in their stories is not bad luck. It is a system that was designed, at every level, to give them less than they were promised. The industry, the regulator, the legislature, and the courts have each played a role in building that system. Each of them has the capacity, and the obligation, to help dismantle the parts of it that cause harm. The question is whether any of them will choose to do so before the next family receives the next denial letter and is told, once again, to read the fine print.
They already know what it says. The problem is that no one made them read it before they signed.
